ATC Group: J05AX29 Fostemsavir

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J05AX29 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J05 Antivirals for systemic use
3 J05A Direct acting antivirals
4 J05AX Other antivirals
5 J05AX29

Active ingredients in J05AX29

Active Ingredient Description
Fostemsavir

Fostemsavir is an HIV-1 antiretroviral agent. It used in combination with other antiretroviral(s) for the treatment of human immunodeficiency virus type 1 (HIV-1) infection,

Related product monographs

Title Information Source Document Type  
RUKOBIA Extended-release tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Austria (AT)

Croatia (HR)

Estonia (EE)

Finland (FI)

France (FR)

Ireland (IE)

Italy (IT)

Lithuania (LT)

Poland (PL)

Romania (RO)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.